We’re pleased to share that the Precision Cancer Consortium (PCC) has been shortlisted for the Precision Medicine Awards in the ‘Innovation & Collaboration of the Year’ category.

The PCC is committed to transforming cancer care through the power of precision oncology, ensuring that every patient has access to comprehensive genomic profiling (CGP). To be recognized for that commitment is both an honor and a reflection of the hard work of all members of the PCC.

We’re grateful to the awards committee for the acknowledgement, and to our members and partner advocates who have made this possible.

—

PCC-192 | June 2025